639500.pdf
As discussed in this chapter, the commercialization and adoption bottlenecks for these moderately complex diagnostics cannot be overcome by technological innovation alone, particularly in the highly regulated and payer-limited healthcare and public health markets. Diagnostics, unlike other clinic...
| Language: | English |
|---|---|
| Published: |
Taylor & Francis
2019
|
